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Abstract: 
Objective:  To assess the impact of intercurrent respiratory infections on infants born <29 weeks 
gestation with bronchopulmonary dysplasia (BPD). 
Study Design:  A retrospective cohort study was conducted on 111 infants born <29 weeks 
gestation with BPD in one academic center from 2008-2010.   
Results:  Backward stepwise logistic regression showed viral infections significantly increased 
oxygen use with an OR of 15.5 [CI 3.4, 71.3].  Stratified bivariate Cochran-Mantel-Hansel chi-
square analysis showed both viral and bacterial infections affected oxygen use (9% vs. 47%, 
p<0.0002 and 8% vs. 24%, p =0.02) with viral infections maintaining significance in the no/mild 
and severe BPD groups (2% vs. 40% p=0.02 and 26% vs. 83% p=0.02).  Both viral and bacterial 
infections were associated with increased steroid use (11% to 29%, P=0.01 and 9% to 22%, 
p=0.03) but only viral infections were associated with an increased diuretic use in the combined 
BPD groups and no/mild BPD group (32% to 57%, P=0.02 and 10% to 50%, p=0.03).  The 
Cochran-Armitage trend test showed that an increasing number of viral infections is associated 
with increased oxygen use (OR [95% CI] = 6.4 [2.3-17.4]), diuretic use (OR [95% CI] = 2.4 [1.1 
– 5.2], p=0.02) and inhaled steroid use (OR [95% CI] = 2.2[1.003 – 5.2], p=0.049). 
Conclusions:  Viral infections caused more long term pulmonary morbidity/mortality than 
bacterial infections on premature lung health over the first year of life. 
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Introduction: 
Each year 1 out of 8 infants are born premature in the United States, costing 
approximately $26.2 billion dollars a year ($51,600 per infant) on their medical care (1, 2) .  
Infants born in the United States before 28 weeks gestation now have a 90% survival rate (3) and 
chronic respiratory morbidity is the most common and costly adverse outcome for these infants 
(4-6).   
Premature infants’ arrested lung development places them at risk for respiratory 
complications in the first year of life.   A “new” form of BPD has developed that is primarily due 
to arrested lung development which involves less inflammation and fibrosis of the airways but 
has increased structural abnormalities (6, 7).  77% of infants born before 30 weeks gestation 
develop BPD (4) and can initially have mild respiratory problems that deteriorate over the first 
year of life (6). These pulmonary abnormalities are not always associated with the infants’ 
presenting level of BPD or respiratory support in the Neonatal Intensive Care Unit (NICU) (8).  
Currently the cause of this unexpected deterioration in lung function is unknown; 
however, other literature has established that respiratory infections in this group has increased 
morbidity associated with it and premature infants have a 73% chance of readmission to the 
hospital for respiratory infections in the first two years of life (9).  Respiratory Syncyntial Virus 
(RSV) is the most common cause for readmission (10); however, Rhinovirus, the most common 
viral pathogen in childhood, can also cause severe respiratory infections in premature infants 
(11-13).   
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BPD, in combination with respiratory infections, may be creating the conditions for an 
epidemic of severe morbidity and deaths among premature infants who appeared to be 
developing successfully.   Recent literature has indicated that even infants with milder BPD may 
be at risk for increased pulmonary morbidity over time but the exact cause of this increased 
morbidity is unclear (6).  The objective of this study was to evaluate the impact of both 
intercurrent bacterial and viral respiratory infections on a cohort of extremely premature infants’ 
pulmonary health over the first year of life past NICU discharge. 
 
METHODS: 
Data Repository:  The data repository of the Center for Infant Pulmonary Disorders is located at 
Children’s Mercy Hospitals and Clinics and provided de-identified data for this study according 
to the process approved by the IRB at Children’s Mercy Hospitals and Clinics (CMH). Infants 
hospitalized at CMH were included in the data repository if they were born less than 29 weeks 
gestational age, born within 2008-2010, born on-sight or transferred to CMH within 24 hours of 
life and had no history of congenital heart disease or structural airway abnormalities.  The data 
repository collects information on the cohort from birth thru five years of live. 
Determination of BPD:  Classification of BPD was performed at 36 weeks gestational age and 
used the criteria outlined by Ehrenkranz et al in 2005 for infants born less than 32 weeks 
gestation (5).  An infant had no BPD if he/she was on room air at 36 weeks or upon discharge 
from the NICU (whichever came first) or if the child was on supplemental oxygen for less than 
28 days.  A diagnosis of BPD was given if the patient was on supplemental oxygen for at least 28 
days.   Infants were classified as:  mild BPD, included patients who were on supplemental 
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oxygen for greater than 28 days but were on room air by discharge or at 36 weeks gestation; 
moderate BPD, if they were on less than 30% supplemental oxygen at 36 weeks gestational age 
or upon discharge; or severe BPD, if they were on 30% or more supplemental oxygen at 36 
weeks gestation/discharge or were on positive pressure ventilation at 36 weeks.  The 
confounding variable of BPD severity was controlled for by stratifying our cohort into three 
groups according to their BPD classification:  none/mild, moderate and severe. 
Definition of Infection:  A bacterial infection was identified in the NICU when the patient was 
clinically symptomatic, there was supporting clinical and/or laboratory/radiographic evidence for 
infection, a bacterial isolate consistent with a respiratory pathogen was obtained from a tracheal 
aspirate, sputum sample or nasal aspirate, and the patient required more than 7 days of antibiotic 
therapy.  Patients who were discharged from the NICU were considered to have a bacterial 
infection if they were given the diagnosis of a bacterial pneumonia/bronchitis from an 
emergency room (ER) physician, pediatrician or hospitalist (with or without supporting 
laboratory data) and prescribed antibiotics for > 7 days.    A viral infection was identified in the 
NICU when the patient was clinically symptomatic and had a virus isolated from a viral 
PCR/culture.  Patients who were discharged from the NICU were considered to have a viral 
infection if they were given the diagnosis of a viral respiratory infection from an ER physician, 
pediatrician or hospitalist (with or without supporting laboratory data).  The patient charts were 
analyzed for evidence of intercurrent respiratory infections by trained data abstractors up to one 
year post NICU discharge.  Medical record reviews included evaluation of the discharge 
summary, 6mo and 12mo follow up visits in the special care NICU clinic, ER notes and hospital 
discharge notes. 
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Study Population:   We included all infants enrolled in the data repository between the dates of 
01/01/2008 thru 12/31/2010 who were less than 29 weeks gestational age at birth and admitted to 
CMH within 24 hours of birth.  We excluded infants who died before 36 weeks corrected 
gestational age, were over 29 weeks gestational age at birth or had significant congenital heart 
disease or structural airway abnormalities.   Out of the 157 infants in the data repository, 15 
infants died before 36 weeks corrected gestational age leaving a total of 142 infants met criteria 
for entry into the study. 
Study Design:   A retrospective (historical) cohort design was used to evaluate the impact of 
intercurrent respiratory infections on lung health in extremely premature infants up to one year of 
age.   
Data Analysis:  Statistical analysis used the SAS programming version 9.2 software package.  
We first performed bivariate analysis between risk factors (BPD, viral infection and bacterial 
infection) and outcome variables (oxygen use, diuretics use and inhaled steroid) using either the 
Chi-square test and/or Fisher’s exact test.   A stratified analysis was then used to assess the 
impact of intercurrent bacterial and viral respiratory infections on the entire cohort and on each 
individual BPD group.  The 2-sided trend t-test was used to evaluate data that did not reach 
statistical significance but appeared to be trending towards significance.  The Cochran-Armitage 
trend test was used to evaluate the impact of multiple infections on outcome variables.  A 
secondary outcome variable of death after NICU discharge was also evaluated.  We developed a 
multivariable model using backwardstepwise logistic regression.  In the multivariate analysis, we 
considered gestational age, gender, severity of BPD, viral infection, bacterial infection, 
viral/bacterial interaction, BPD/viral interaction, BPD/bacterial interactions and birth weight on 
their association with the outcome variables.  Odds ratio (OR) and 95% confidence interval (CI) 
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of OR were reported. To keep model parsimony, non-significant factors are removed from the 
multivariate models. Statistical significance were claimed with p<0.05.   
RESULTS: 
Basic demographic information on gender, gestational age and birth weight was collected 
on the 111 infant cohort (Table 1).   
 
Table 1:  Patient demographic information. 
 
Out of the initial 157 infants, 15 died before 36 weeks corrected gestational age (Figure 
1).  This left a sample size of 142 patients that underwent BPD classification using the 
Ehrenkranz model (5).  These infants were then separated into three groups for our study which 
included no/mild BPD (66/142), moderate BPD (45/142) and severe BPD (31/142).  Of the 142 
children, 31 patients died or were LFU including 14 patients LFU and 1 death in the no/mild 
BPD group, 7 patients LFU and 3 deaths in the moderate BPD group and 4 LFU and 2 deaths in 
the severe BPD group.  Complete data was available on 51 patients in the no/mild BPD group, 
35 patients in the moderate BPD group and 25 patients in the severe BPD group.  Of the 35 
patients in the mild/no BPD group there were 17 bacterial infections and 5 viral infections 
identified;  2 patients had overlapping infections identified.  Of the 35 patients in the moderate 
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BPD group there were 15 bacterial infections and 7 viral infections identified; 2 patients had 
overlapping infections identified.  Of the 25 patients in the severe BPD group there were 17 
bacterial infections and 6 viral infections identified; 4 patients had overlapping infections 
identified.  Increasing BPD severity was associated with increasing oxygen, diuretic and inhaled 
steroid use among patients with no/mild, moderate and severe BPD respectively (P<0.0003, 
P<0.0001 and P<0.0001).  Oxygen use was 6%, 11%, and 40%, increasing inhaled steroid use 
was 3%, 16% and 39%, and increasing diuretic use was 14%, 44%, and 71%.   
 
Figure 1:  Patient flow diagram over the 12 month study period. 
157 Patients
15  died before 36 
weeks
Mild/No BPD
66/142 Patients
Moderate BPD
45/142 Patients
Severe BPD
31/142 Patients
1 died
14 LFU
3 died
7 LFU
2 died
4 LFU
12 Month F/U Period  (N: 111)
Mild/No BPD
51/111 Patients
Moderate BPD
35/111 Patients
Severe BPD
25/111 Patients
None (31 )
02: 0% n=0
D: 10%  n=3
iSter: 3% n=1
Viral (5)
O2: 40% n=2
D: 60% n=3
iSter: 0% n=0
Bacterial (17)
O2: 12% n=2
D: 18% n=3
iSter: 6% n=1
None ( 15 )
O2:  7%  n=1
D: 60% n=9
iSter: 7% n=1
None ( 6 )
O2: 17% n=1
D: 50% n=3
iSter: 17% n=1
Viral (7)
O2: 14% n=1
D: 14% n=1
iSter: 43% n=3
Viral (6) 
O2: 83% n=5
D: 100% n=6
iSter: 67% n=4
Bacterial (15) 
O2: 7% n=1
Diur: 40% n=6
iSter: 20% n=3
Bacterial (17)
O2: 47% n=8
D: 71% n=12
iSter: 53% n=9
Both: 2 Both: 2 Both: 4
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To evaluate the impact of intercurrent respiratory tract infections on three primary 
outcome variables (oxygen use, inhaled steroid use and diuretic use at 12 months) in each BPD 
group, we then used a stratified bivariate analysis using the Cochran-Mantel Haenszel chi-square 
modeling to assess the impact of both bacterial and viral infections on our outcome variables in 
each of the defined BPD groups.  A logarithmic regression model showed that there was not 
significant interaction between the viral and bacterial infections (OR[95%]=2.1[0.1, 38.3], 
p=0.61).   
Intercurrent bacterial and viral infections were associated with significantly higher 
oxygen use when all BPD groups were combined with a significantly greater impact seen in the 
viral group (8% vs 24%, p=0.02 and 9% vs 47%, p<0.0002 respectively)(Table 2).  Bacterial 
infections did not statistically influence the oxygen use in any of the three BPD sub-groups; 
however, intercurrent viral infections did statistically increase oxygen use at 12 months post 
NICU discharge:  2% vs. 40% O2 use in the no/mild BPD (p: 0.02) and 26% vs. 83% in the 
severe BPD group (p:0.02)(Table 2).  The intercurrent bacterial infections did not show a 
statistically significant change in oxygen use; however, there did seem to be a trend towards 
significance so the trend t-test was used to see if a statistically significant trend was seen in the 
bacterial infection cohort and a z score of 0.0963 did show a marginally significant trend towards 
increased oxygen use in this cohort.   
 
Table 2:  CMH chi-square analysis comparing bacterial and viral impact on three outcome 
variables (oxygen use, diuretic use and inhaled steroid use) in infants with mild, moderate and 
severe BPD.   
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The intercurrent bacterial and viral infections were associated with increased inhaled 
steroid use in the combined BPD groups, but not in any individual BPD groupings.  Bacterial 
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infections increased the use from 9% to 22% (p=0.03) and viral infections increased the use from 
11% to 29% (p=0.01)(Table 2). 
The intercurrent respiratory infections were associated with increased diuretic use in the 
viral group only.  The viral impact on the combined BPD group analysis was 32% vs. 57% 
(p=0.02).  When the BPD subgroups were broken apart, the no/mild BPD group continued to 
show a significant increase in diuretic use (10% vs. 50%, p=0.03) (Table 2). 
The data was then analyzed, using the Cochran-Armitage trend test, to see if an 
increasing number of viral or bacterial infections impacted the three primary outcome variables.  
We first looked at the impact of increasing viral infections on oxygen use.  Increasing number of 
viral infections was noted to cause a greater impact on oxygen use (OR [95% CI] = 6.4 [2.3 – 
17.4], p=0.0003): at baseline 9% of the cohort required oxygen which increased with increasing 
number of viral infections to 44% with 1 viral infection and 67% with 2 viral infections.   
Increasing number of viral infections also caused a moderate impact on diuretic use (OR [95% 
CI] = 2.4 [1.1 – 5.2], p=0.02): at baseline 32% of the cohort required diuretics which increased 
with increasing number of viral infections to 53% with 1 viral infection and 75% with 2 viral 
infections.  Increasing number of viral infections also caused a slight impact on the inhaled 
steroid use (OR [95% CI] = 2.2[1.003 – 5.2], p=0.049): at baseline 12% of the cohort required 
inhaled steroids which increased with increasing number of viral infections to 32% with 1 viral 
infection and 25% with 2 viral infections. With increasing bacterial infections we saw an 
increase in oxygen use from 8% at baseline to 24% with 1 infection, 29% with 2 infections 
(p=0.05), an increase in diuretics use from 31% at baseline to 41% with 1 infection, 50% with 2 
infections (p=0.07), and an increase in oxygen use from 9% at baseline to 22% with 1 infection, 
25% with 2 infections (p=0.07), but they are not statistically significant.  
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Three separate logistic regression models were created for each of our three primary 
outcome variables.  We forced the following variables into each model:  gestational age, BPD 
class, viral infection and bacterial infection).  We originally included the variables gender and 
viral*bacterial variables but these were excluded after backwardstepwise regression.  Viral 
infections were shown to increase oxygen use (OR[95%]=15.57 [3.4, 71.28], p=0.0004)(Table 
3).  The model had 89.3% prediction accuracy.  There was no significant interaction between 
viral and bacterial infections (OR[95%]=2.1[0.1, 38.3], p=0.61).  
 
Table 3:  Logistic regression models for the three outcome variables of oxygen use, inhaled 
steroid use and diuretic use. 
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Finally, the secondary outcome variable of death after NICU discharge was evaluated 
using bivariate analysis.  Seven infants were identified (5% of the cohort) who died after NICU 
discharge.  6/7 infants had recent or ongoing viral infections at the time of their death 
(p<0.0001).  One had mild BPD, three had moderate BPD and two had severe BPD.  These 
deaths do not appear to correlate with the 36 week BPD severity assessment.  3/6 infants had a 
history of adrenal insufficiency during their NICU stay and 4/6 infants had a history of transient 
pulmonary hypertension in the NICU; however, the sample size for these observations were too 
small to draw any meaningful conclusions. 
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DISCUSSION: 
This study evaluated the impact of both bacterial and viral infections on the same cohort 
of extremely premature infants at the same time.  We demonstrated that viral infections had a 
significantly greater impact on premature lung health over time compared to bacterial infections.  
Increasing number of viral infections also had a significant impact on premature infant lung 
morbidity while increasing number of bacterial infections did not.   
 To understand why viral infections appear to affect BPD lung physiology differently 
than bacterial infections it is important to understand how BPD lung structure differs from a full 
term infants lung physiology.  BPD lung structure consists of a simplified alveolar architecture 
(7, 15) with less alveolar area for ventilation as well as a decreased intravascular pulmonary 
network that affects the perfusion to the lung (16-18).  In the short term, this leads to less 
baseline pulmonary reserve which is further compromised by infection mediated inflammation in 
the lungs causing more V/Q mismatch.   
Viral infections have been shown to remain in lung tissue for over a month after the acute 
infection has resolved, causing prolonged abnormal inflammatory responses (19, 20).  Viral 
infections have also been linked to development of airway hyper reactivity and asthma in later 
life (21) which further demonstrates the long lasting impact of viral infections on the pulmonary 
physiology.  Since viruses persist in the lung longer than bacteria, it is not surprising that our 
cohort had worse pulmonary outcomes at one year with a history of viral as opposed to bacterial 
intercurrent lung infections.  Also, recent animal studies have indicated that supplemental 
oxygen increases an animal’s sensitivity to influenza infection through altered inflammatory 
pathways (22)which adds biologic plausibility to our clinical findings linking greater lung 
morbidity in premature infants at a year of age who have had intercurrent viral infections.  It is 
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surprising to see how much more striking the increased morbidity is with the viral as opposed to 
bacterial infections. 
There were several limitations in our study design that must be considered when 
evaluating these results.  All of these infants were from one center and our findings may not be 
generalizable to the population at large.  Also, obtaining long-term data on NICU infants can be 
challenging, especially when the NICU cares for infants who are born over 100 miles away.  
Therefore, some infants were LFU up after NICU discharge.  Some of these infants could have 
moved out of state and died in another center or have significant pulmonary morbidity that was 
being managed at another location.  Another limitation was our definition of infections.  While 
the patients were in the NICU we had better control over management; however, once the 
patients were in the community the type of work-up they obtained varied and did not always 
include the same supporting laboratory/radiographic studies.  They were also not being evaluated 
on a daily basis and it is likely that minor infections, both bacterial/viral, went unnoticed by care 
givers. 
There were several strengths in our study design.  We evaluated infants that were born 
recently (2008-2010) and had been hospitalized within the same hospital within 24 hours of 
birth.  This study design minimized the variability of ventilatory strategies used on this cohort 
since they were managed by the same group of physicians incorporating the goal of quick 
transition from invasive to non-invasive ventilatory support.  Since our cohort was born recently 
and only spans over three years, the impact of changing technology and medical therapies over 
time was minimized.  Also, our study required access to medical records for this cohort past 
NICU discharge with special interest being placed on ER, hospital and primary care provider 
records.  Since this center is the only tertiary referral center for complex children in this 
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geographic region, we hospitalize over 86% of pediatric cases (unpublished CMH demographic 
data) and closer to 100% of high risk pediatric cases which this cohort falls into.  The NICU also 
has a multispecialty clinic (the special care clinic) that follows the NICU graduates over time 
with outside pediatrician support and access to their outside records.  They see the patients 
frequently for at least a year past NICU discharge and the CMH-DR has permission to collect 
information on participants up to five years post NICU discharge.   
In general, there has been variability between post-NICU discharge management for this 
patient population and literature on long-term pulmonary outcomes in this population has only 
recently become available.  Current post-NICU BPD management focuses mainly on nutrition, 
growth and neurological outcome.  Several studies on home oxygen therapy and weaning 
strategies have been proposed(14, 23, 24); however, there still remains a wide variability in 
practice in the pediatric providers(25).  Even the efficacy of reducing healthcare expenditures in 
this patient population with outpatient pulmonary follow-up is unclear.  However, recent 
literature has shown that pulmonary follow-up keeps the ER visits and hospitalization rates 
between mild and severe BPD patients stable (26) when normally more severe BPD patients 
have increased sequelae.  Previous recommendations for evaluation of sleep disordered breathing 
in this population was focused on infants with severe BPD; however, recent studies have shown 
that daytime oxygen saturations and respiratory rates did not predict instability seen on sleep 
studies (27).  A recent study performing serial infant pulmonary function tests did not 
demonstrate any “catch up” lung growth in the BPD infants in the first year of life (28).  Longer 
term studies that looked at lung health in teenagers/adults with a history of BPD showed 
persistent abnormalities in lung function as seen by increased air trapping, increased residual 
volume, increased incidence of airway hyper reactivity and a faster decline in lung function in 
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adulthood compared with controls (29-31). While the longer term pulmonary outcomes were 
preformed on groups of infants that fell into both the “old” and “new” definitions of BPD, these 
findings still have significant implications for the type of long term pulmonary follow up these 
patients should be receiving.  Not all BPD patients are followed by multi-specialty clinics with 
pediatric pulmonology support and even between pediatric pulmonologists there is significant 
variability among management.  Our study suggests that a wider range of extremely premature 
infants may be at risk of significant pulmonary sequelae from intercurrent infections and warrant 
closer observation in not just long-term pulmonary follow up but also shorter-term management 
as well.   Patients with a history of extreme prematurity with mild/moderate BPD with an acute 
viral URI who are mildly hypoxic should be monitored closely and physicians may need to have 
a low threshold for obtaining a cardiac echo to evaluate for transient pulmonary hypertension and 
consideration of hospitalization for observation.  This population also warrants closer 
observation for sleep disordered breathing and patients with mild/moderate BPD may benefit 
from screening for sleep disordered breathing before they leave the NICU.  There should be a 
low provider threshold for obtaining a sleep study if abnormalities are suspected in clinical 
history despite reassuring pulse oximetry and respiratory rates obtained in clinic.   
   Finally, our cohort had 7 individuals (6%) die post NICU discharge and six were 
associated with acute viral infections.  The sample size was not large enough to draw any 
statistically significant conclusions from; however, it was noted that 3/7 infants had adrenal 
insufficiency and 4/7 infants had transient pulmonary hypertension while in the NICU.  Some of 
these patients, and other cohort participants who did not die, were noted to have pulmonary 
hypertension with hospitalizations secondary to viral illnesses which was not noted on NICU 
discharge cardiac ECHO.  We hypothesize that there may be an increased risk for developing 
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transient pulmonary HTN in this population with intercurrent viral illnesses after NICU 
discharge and larger studies will have to be performed to corroborate this clinical observation 
and determine potential risk factors for this outcome.  The other possibility is that our cardiac 
echo technique does not allow us to adequately evaluate this population for very mild persistent 
pulmonary hypertension and other markers will need to be developed to detect pulmonary 
hypertension in this patient population.  Larger studies with national datasets should also be 
performed to determine if this trend seen in our patient population can be generalized to the 
larger US population of premature infants. 
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